Benzinga's Top Upgrades

Analysts at Goldman Sachs upgraded

from Sell to Neutral. The price target for Myriad Genetics has been raised from $31 to $40. Myriad Genetics shares closed at $42.76 on Monday. Analysts at Morgan Stanley upgraded

from Underweight to Equal-weight. The price target for Kellogg has been raised from $65 to $69. Kellogg shares closed at $70.52 on Monday. Topeka Capital upgraded

from Hold to Buy. The price target for Lamar Advertising has been raised from $60 to $73. Lamar Advertising shares closed at $58.49 on Monday. Wunderlich upgraded

from Hold to Buy. The price target for ALLETE has been raised from $54 to $55. ALLETE shares closed at $49.80 on Monday. Analysts at Citigroup upgraded

from Neutral to Buy. The price target for FireEye has been raised from $31 to $35. FireEye shares closed at $20.19 on Monday. Analysts at Stifel Nicolaus upgraded

from Hold to Buy. Wabco Holdings shares closed at $100.02 on Monday. Analysts at Piper Jaffray upgraded

from Underweight to Neutral. The price target for BBCN Bancorp has been raised from $15 to $19. BBCN Bancorp shares closed at $18.18 on Monday. BMO Capital upgraded

from Market Perform to Outperform. Douglas Emmett shares closed at $30.72 on Monday. Argus Research upgraded

from Hold to Buy. Hershey shares closed at $87.14 on Monday. Bank of America upgraded

from Neutral to Buy. The price target for Ares Management has been lowered from $19 to $18. Ares Management shares closed at $13.62 on Monday.